Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001225208-22-011138
Filing Date
2022-10-26
Accepted
2022-10-26 16:47:36
Documents
2
Period of Report
2022-10-17

Document Format Files

Seq Description Document Type Size
1 doc3.html 3  
1 doc3.xml 3 11932
2 forminardpoa1.txt EX-24 3946
  Complete submission text file 0001225208-22-011138.txt   17181
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0101
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933
Business Address
Forminard Elizabeth (Reporting) CIK: 0001950802 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-03215 | Film No.: 221333785